176 related articles for article (PubMed ID: 17679095)
1. Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b.
Peschard P; Kozlov G; Lin T; Mirza IA; Berghuis AM; Lipkowitz S; Park M; Gehring K
Mol Cell; 2007 Aug; 27(3):474-85. PubMed ID: 17679095
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for UBA-mediated dimerization of c-Cbl ubiquitin ligase.
Kozlov G; Peschard P; Zimmerman B; Lin T; Moldoveanu T; Mansur-Azzam N; Gehring K; Park M
J Biol Chem; 2007 Sep; 282(37):27547-27555. PubMed ID: 17635922
[TBL] [Abstract][Full Text] [Related]
3. Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b.
Davies GC; Ettenberg SA; Coats AO; Mussante M; Ravichandran S; Collins J; Nau MM; Lipkowitz S
Oncogene; 2004 Sep; 23(42):7104-15. PubMed ID: 15273720
[TBL] [Abstract][Full Text] [Related]
4. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
5. Differential ubiquitin binding of the UBA domains from human c-Cbl and Cbl-b: NMR structural and biochemical insights.
Zhou ZR; Gao HC; Zhou CJ; Chang YG; Hong J; Song AX; Lin DH; Hu HY
Protein Sci; 2008 Oct; 17(10):1805-14. PubMed ID: 18596201
[TBL] [Abstract][Full Text] [Related]
6. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination.
Bezsonova I; Bruce MC; Wiesner S; Lin H; Rotin D; Forman-Kay JD
Biochemistry; 2008 Aug; 47(34):8937-49. PubMed ID: 18680311
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into the mechanisms of CIN85 SH3 domains binding to Cbl proteins: solution-based investigations and in vivo implications.
Ababou A; Pfuhl M; Ladbury JE
J Mol Biol; 2009 Apr; 387(5):1120-36. PubMed ID: 19268472
[TBL] [Abstract][Full Text] [Related]
9. Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3.
Dou H; Buetow L; Sibbet GJ; Cameron K; Huang DT
Nat Struct Mol Biol; 2013 Aug; 20(8):982-986. PubMed ID: 23851457
[TBL] [Abstract][Full Text] [Related]
10. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.
Feshchenko EA; Smirnova EV; Swaminathan G; Teckchandani AM; Agrawal R; Band H; Zhang X; Annan RS; Carr SA; Tsygankov AY
Oncogene; 2004 Jun; 23(27):4690-706. PubMed ID: 15107835
[TBL] [Abstract][Full Text] [Related]
11. Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix.
Schmidt MHH; Husnjak K; Szymkiewicz I; Haglund K; Dikic I
Oncogene; 2006 May; 25(21):3071-8. PubMed ID: 16407834
[TBL] [Abstract][Full Text] [Related]
12. Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes.
Veselits M; Tanaka A; Lipkowitz S; O'Neill S; Sciammas R; Finnegan A; Zhang J; Clark MR
PLoS One; 2014; 9(3):e89792. PubMed ID: 24651487
[TBL] [Abstract][Full Text] [Related]
13. The protein content of an adaptor protein, STAP-2 is controlled by E3 ubiquitin ligase Cbl.
Sekine Y; Yamamoto C; Ikeda O; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(2):187-92. PubMed ID: 19401194
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of the TKB domain of ubiquitin ligase Cbl-b complexed with its small inhibitory peptide, Cblin.
Ohno A; Ochi A; Maita N; Ueji T; Bando A; Nakao R; Hirasaka K; Abe T; Teshima-Kondo S; Nemoto H; Okumura Y; Higashibata A; Yano S; Tochio H; Nikawa T
Arch Biochem Biophys; 2016 Mar; 594():1-7. PubMed ID: 26874193
[TBL] [Abstract][Full Text] [Related]
15. The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.
Ryan PE; Sivadasan-Nair N; Nau MM; Nicholas S; Lipkowitz S
J Biol Chem; 2010 Jul; 285(31):23687-98. PubMed ID: 20525694
[TBL] [Abstract][Full Text] [Related]
16. Cbl-b and c-Cbl negatively regulate osteoblast differentiation by enhancing ubiquitination and degradation of Osterix.
Choi YH; Han Y; Lee SH; Jin YH; Bahn M; Hur KC; Yeo CY; Lee KY
Bone; 2015 Jun; 75():201-9. PubMed ID: 25744063
[TBL] [Abstract][Full Text] [Related]
17. CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.
Calco GN; Stephens OR; Donahue LM; Tsui CC; Pierchala BA
J Biol Chem; 2014 Mar; 289(11):7307-19. PubMed ID: 24425877
[TBL] [Abstract][Full Text] [Related]
18. The Cbl family proteins: ring leaders in regulation of cell signaling.
Swaminathan G; Tsygankov AY
J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
Liu Q; Zhou H; Langdon WY; Zhang J
Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the ubiquitin-associated domain of human BMSC-UbP and its complex with ubiquitin.
Chang YG; Song AX; Gao YG; Shi YH; Lin XJ; Cao XT; Lin DH; Hu HY
Protein Sci; 2006 Jun; 15(6):1248-59. PubMed ID: 16731964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
